Human Interleukin-1 Beta ELISA

Interleukin-1 beta (IL-1β) is a key pro-inflammatory cytokine that plays a central role in the initiation and progression of cardiovascular inflammation, particularly in atherosclerosis and myocardial injury, and is considered an important mediator linking inflammation to cardiovascular disease. Increased IL-1β activity contributes to endothelial dysfunction, plaque formation, plaque destabilization, and adverse cardiac remodeling following myocardial infarction. In cardiovascular research, IL-1β is widely studied as a biomarker and therapeutic target, supported by evidence that inhibition of the IL-1β pathway can reduce recurrent cardiovascular events in high-risk patients. Elevated IL-1β levels have been associated with acute coronary syndromes, heart failure, and other inflammatory cardiovascular conditions, reflecting ongoing vascular and myocardial inflammation.

References on the product +5